The in vivo immunization of this NP demonstrated excellent tumor targeting and cancericidal capabilities through downregulating several antioxidative and anti-ferroptosis proteins and STING-induced CD8+ T-cell response [123]. The gene discussed is STING1; the disease is neoplasm.